A study of molecular markers with potential prognostic and predictive value (c-erb b-2, p53, cyclin D1, MIB1, ER and PgR) in locally advanced breast cancer treated with neo-adjuvant dose intensive chemotherapy in an EORTC-NCIC-SAKK randomized phase III study

Locally Advanced ◽

Phase Iii ◽

Intensive Chemotherapy ◽

P3-14-02: Sequential Versus Upfront Intensified Neoadjuvant Chemotherapy in Patients with Large Resectable or Locally Advanced Breast Cancer (INTENS), Toxicity Results from a Phase III Study of the Dutch Breast Cancer Trialists' Group (BOOG).

10.1158/0008-5472.sabcs11-p3-14-02 ◽

2011 ◽

Author(s):

BE Vriens ◽

de Vijver KK Van ◽

C Boetes ◽

Gastel SM van ◽

J Wals ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Phase Iii ◽

154P Five-year follow-up of the phase III study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in patients with HER2 positive early or locally advanced breast cancer

Annals of Oncology ◽

10.1016/j.annonc.2021.08.435 ◽

2021 ◽

Vol 32 ◽

pp. S428

Author(s):

X. Pivot ◽

O. Burian ◽

F. Bazan ◽

M. Wojtukiewicz ◽

H. Jang ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Phase Iii ◽

Her2 Positive ◽

Abstract P6-17-17: Pertuzumab, trastuzumab, and docetaxel for HER2-positive early or locally advanced breast cancer in the neoadjuvant setting: Efficacy and safety analysis of a randomized phase III study in Asian patients (PEONY)

10.1158/1538-7445.sabcs18-p6-17-17 ◽

2019 ◽

Cited By ~ 1

Author(s):

Z Shao ◽

D Pang ◽

H Yang ◽

W Li ◽

S Wang ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Locally Advanced ◽

Safety Analysis ◽

Phase Iii ◽

Efficacy And Safety ◽

Her2 Positive ◽

Asian Patients ◽

Conservative local treatment versus mastectomy after induction chemotherapy in locally advanced breast cancer: A randomised phase III study (EORTC 10974/22002, LAMANOMA) – Why did this study fail?

European Journal of Cancer ◽

10.1016/j.ejca.2005.06.027 ◽

2005 ◽

Vol 41 (18) ◽

pp. 2787-2788 ◽

Cited By ~ 9

Author(s):

Marcin Sinacki ◽

Jacek Jassem ◽

Geertjan van Tienhoven

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Induction Chemotherapy ◽

Locally Advanced ◽

Local Treatment ◽

Advanced Breast ◽

Phase Iii ◽

Abstract P1-11-10: Sequential Versus Upfront Intensified Neoadjuvant Chemotherapy in Patients with Large Resectable or Locally Advanced Breast Cancer (INTENS), First Results from a Phase III Study of the Dutch Breast Cancer Trialists’ Group (BOOG)

10.1158/0008-5472.sabcs10-p1-11-10 ◽

2010 ◽

Cited By ~ 2

Author(s):

BE Vriens ◽

KK Van de Vijver ◽

C Boetes ◽

SM van Gastel ◽

J Wals ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Phase Iii ◽

First Results ◽

3-year follow-up of a phase III study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in HER2 positive early or locally advanced breast cancer in neoadjuvant setting

The Breast ◽

10.1016/s0960-9776(19)30257-7 ◽

2019 ◽

Vol 44 ◽

pp. S68

Author(s):

X. Pivot ◽

I. Bondarenko ◽

M. Dvorkin ◽

T. Sarosiek ◽

M. Wojtukiewicz ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Phase Iii ◽

Her2 Positive ◽

Predictive value of survivin alternative transcript expression in locally advanced breast cancer patients treated with neoadjuvant chemotherapy

International Journal of Molecular Medicine ◽

10.3892/ijmm_00000129 ◽

1998 ◽

Author(s):

Lizard-Nacol

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Predictive Value ◽

Locally Advanced ◽

Alternative Transcript ◽

Transcript Expression ◽

Breast Cancer Patients

Prognostic and predictive value of changes in tumour cell proliferation in locally advanced breast cancer primarily treated with doxorubicin

Oncology Reports ◽

10.3892/or.13.3.525 ◽

2005 ◽

Author(s):

Turid Aas ◽

Stephanie Geisler ◽

Hildegunn Helle ◽

Anne-Lise Børresen-Dale ◽

Per Lønning ◽

...

Keyword(s):

Breast Cancer ◽

Cell Proliferation ◽

Advanced Breast Cancer ◽

Tumour Cell ◽

Predictive Value ◽

Locally Advanced ◽

Advanced Breast ◽

Tumour Cell Proliferation

Dose-intensive chemotherapy for locally advanced breast cancer

Current Oncology Reports ◽

10.1007/s11912-999-0006-6 ◽

1999 ◽

Vol 1 (1) ◽

pp. 23-30 ◽

Cited By ~ 2

Author(s):

Jolanda G. Schrama ◽

Sjoerd Rodenhuis

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Intensive Chemotherapy

The added value of the combined evaluation of clinical efficacy, quality of life and cost-effectiveness in a randomized phase III study. Results of an EORTC — NCIC — SAKK neoadjuvant trial in patients with locally advanced breast cancer (LABC)

European Journal of Cancer ◽

10.1016/s0959-8049(99)81671-2 ◽

1999 ◽

Vol 35 ◽

pp. S313

Author(s):

P. Therasse ◽

L. Mauriac ◽

M. Welnicka ◽

P. Bruning ◽

T. Cufer ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Cost Effectiveness ◽

Locally Advanced ◽

Added Value ◽

Phase Iii ◽

Study Results ◽